SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '5voc'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1FBM_B_RTLB951_0 (PROTEIN (CARTILAGE OLIGOMERIC MATRIX PROTEIN))	5voc	ENVELOPE GLYCOPROTEIN H (Human betaherpesvirus 5)	4 / 4	THR A 453 LEU A 450 LEU A 469 GLN A 375	None	1.18A	1fbmA-5vocA: undetectable	1fbmA-5vocA: 5.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1L2I_B_CCSB417_0 (ESTROGEN RECEPTOR)	5voc	ENVELOPE GLYCOPROTEIN UL131A (Human betaherpesvirus 5)	4 / 6	PRO E 45 GLN E 47 LYS E 51 VAL E 53	None None NAG E 201 ( 4.9A) None	1.46A	1l2iB-5vocE: undetectable	1l2iB-5vocE: 18.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1SKX_A_RFPA1_2 (ORPHAN NUCLEAR RECEPTOR PXR)	5voc	ENVELOPE GLYCOPROTEIN H ENVELOPE GLYCOPROTEIN L (Human betaherpesvirus 5)	4 / 5	PHE B 232 LEU B 246 MET A 92 LEU B 56	None	1.48A	1skxA-5vocB: undetectable	1skxA-5vocB: 22.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1UW6_D_NCTD1208_1 (ACETYLCHOLINE-BINDIN G PROTEIN)	5voc	ENVELOPE GLYCOPROTEIN H ENVELOPE GLYCOPROTEIN L (Human betaherpesvirus 5)	4 / 8	TYR A 61 CYH B 233 LEU A 96 MET A 92	None	1.46A	1uw6D-5vocA: undetectable 1uw6E-5vocA: undetectable	1uw6D-5vocA: 14.07 1uw6E-5vocA: 14.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1UW6_G_NCTG1206_1 (ACETYLCHOLINE-BINDIN G PROTEIN)	5voc	ENVELOPE GLYCOPROTEIN H ENVELOPE GLYCOPROTEIN L (Human betaherpesvirus 5)	4 / 8	TYR A 61 CYH B 233 LEU A 96 MET A 92	None	1.49A	1uw6G-5vocA: undetectable 1uw6H-5vocA: undetectable	1uw6G-5vocA: 14.07 1uw6H-5vocA: 14.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1UW6_P_NCTP1206_1 (ACETYLCHOLINE-BINDIN G PROTEIN)	5voc	ENVELOPE GLYCOPROTEIN H ENVELOPE GLYCOPROTEIN L (Human betaherpesvirus 5)	4 / 8	TYR A 61 CYH B 233 LEU A 96 MET A 92	None	1.47A	1uw6P-5vocA: undetectable 1uw6Q-5vocA: undetectable	1uw6P-5vocA: 14.07 1uw6Q-5vocA: 14.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1UW6_T_NCTT1208_1 (ACETYLCHOLINE-BINDIN G PROTEIN)	5voc	ENVELOPE GLYCOPROTEIN H ENVELOPE GLYCOPROTEIN L (Human betaherpesvirus 5)	4 / 8	LEU A 96 MET A 92 TYR A 61 CYH B 233	None	1.42A	1uw6P-5vocA: undetectable 1uw6T-5vocA: undetectable	1uw6P-5vocA: 14.07 1uw6T-5vocA: 14.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1Y0X_X_T44X500_2 (THYROID HORMONE RECEPTOR BETA-1)	5voc	ENVELOPE GLYCOPROTEIN H (Human betaherpesvirus 5)	4 / 5	ILE A 597 SER A 577 ARG A 528 LEU A 596	None	1.16A	1y0xX-5vocA: undetectable	1y0xX-5vocA: 16.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2OAX_F_SNLF6001_1 (MINERALOCORTICOID RECEPTOR)	5voc	ENVELOPE GLYCOPROTEIN H (Human betaherpesvirus 5)	5 / 12	LEU A 348 ALA A 345 LEU A 313 THR A 272 PHE A 250	None	1.46A	2oaxF-5vocA: undetectable	2oaxF-5vocA: 15.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2QD4_A_CHDA803_0 (FERROCHELATASE)	5voc	ENVELOPE GLYCOPROTEIN L (Human betaherpesvirus 5)	4 / 5	LEU B 253 PRO B 254 LEU B 257 ILE B 219	None	0.70A	2qd4A-5vocB: undetectable	2qd4A-5vocB: 23.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2R2V_D_ACTD36_0 (GCN4 LEUCINE ZIPPER)	5voc	ENVELOPE GLYCOPROTEIN H (Human betaherpesvirus 5)	3 / 3	SER A 316 TYR A 320 HIS A 318	None	0.81A	2r2vD-5vocA: undetectable	2r2vD-5vocA: 3.66
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2UVN_A_ECNA1409_1 (CYTOCHROME P450 130)	5voc	ENVELOPE GLYCOPROTEIN L (Human betaherpesvirus 5)	5 / 12	LEU B 123 ASP B 117 THR B 153 GLY B 161 LEU B 82	None	1.20A	2uvnA-5vocB: undetectable	2uvnA-5vocB: 21.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2V0M_D_KLND1498_1 (CYTOCHROME P450 3A4)	5voc	ENVELOPE GLYCOPROTEIN H (Human betaherpesvirus 5)	5 / 11	ILE A 227 ALA A 341 THR A 337 GLU A 221 LEU A 333	None	1.39A	2v0mD-5vocA: undetectable	2v0mD-5vocA: 22.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2W3B_B_FOLB401_1 (DIHYDROFOLATE REDUCTASE)	5voc	ENVELOPE GLYCOPROTEIN H (Human betaherpesvirus 5)	3 / 3	GLU A 466 GLN A 151 ARG A 365	None	0.98A	2w3bB-5vocA: undetectable	2w3bB-5vocA: 13.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2XNR_A_ACTA1001_0 (NUCLEAR POLYADENYLATED RNA-BINDING PROTEIN 3)	5voc	ENVELOPE GLYCOPROTEIN UL130 (Human betaherpesvirus 5)	3 / 3	SER D 67 ARG D 66 GLN D 70	None	0.81A	2xnrA-5vocD: undetectable	2xnrA-5vocD: 18.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y69_C_CHDC1265_0 (CYTOCHROME C OXIDASE POLYPEPTIDE 7A1 CYTOCHROME C OXIDASE SUBUNIT 3)	5voc	ENVELOPE GLYCOPROTEIN H ENVELOPE GLYCOPROTEIN L (Human betaherpesvirus 5; Human betaherpesvirus 5)	4 / 5	PHE A 90 PHE A 80 LEU B 183 PHE B 222	None	1.15A	2y69C-5vocA: 2.5 2y69J-5vocA: undetectable	2y69C-5vocA: 15.48 2y69J-5vocA: 7.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y69_P_CHDP1265_0 (CYTOCHROME C OXIDASE POLYPEPTIDE 7A1 CYTOCHROME C OXIDASE SUBUNIT 3)	5voc	ENVELOPE GLYCOPROTEIN H ENVELOPE GLYCOPROTEIN L (Human betaherpesvirus 5; Human betaherpesvirus 5)	4 / 5	PHE A 90 PHE A 80 LEU B 183 PHE B 222	None	1.19A	2y69P-5vocA: 2.6 2y69W-5vocA: undetectable	2y69P-5vocA: 15.48 2y69W-5vocA: 7.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2ZZN_A_SAMA401_0 (UNCHARACTERIZED PROTEIN MJ0883)	5voc	ENVELOPE GLYCOPROTEIN H (Human betaherpesvirus 5)	5 / 12	ARG A 188 PHE A 234 ILE A 249 VAL A 236 PHE A 342	None	0.97A	2zznA-5vocA: undetectable	2zznA-5vocA: 16.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3ABL_P_CHDP1271_0 (CYTOCHROME C OXIDASE POLYPEPTIDE 7A1 CYTOCHROME C OXIDASE SUBUNIT 3)	5voc	ENVELOPE GLYCOPROTEIN H ENVELOPE GLYCOPROTEIN L (Human betaherpesvirus 5; Human betaherpesvirus 5)	4 / 6	PHE A 90 PHE A 80 LEU B 183 PHE B 222	None	1.18A	3ablP-5vocA: 2.6 3ablW-5vocA: undetectable	3ablP-5vocA: 15.48 3ablW-5vocA: 6.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3ABM_C_CHDC271_0 (CYTOCHROME C OXIDASE POLYPEPTIDE 7A1 CYTOCHROME C OXIDASE SUBUNIT 3)	5voc	ENVELOPE GLYCOPROTEIN H ENVELOPE GLYCOPROTEIN L (Human betaherpesvirus 5; Human betaherpesvirus 5)	4 / 5	PHE A 90 PHE A 80 LEU B 183 PHE B 222	None	1.14A	3abmC-5vocA: 2.6 3abmJ-5vocA: undetectable	3abmC-5vocA: 15.48 3abmJ-5vocA: 6.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3ABM_P_CHDP1271_0 (CYTOCHROME C OXIDASE POLYPEPTIDE 7A1 CYTOCHROME C OXIDASE SUBUNIT 3)	5voc	ENVELOPE GLYCOPROTEIN H ENVELOPE GLYCOPROTEIN L (Human betaherpesvirus 5; Human betaherpesvirus 5)	4 / 5	PHE A 90 PHE A 80 LEU B 183 PHE B 222	None	1.16A	3abmP-5vocA: 2.8 3abmW-5vocA: undetectable	3abmP-5vocA: 15.48 3abmW-5vocA: 6.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3AG3_C_CHDC271_0 (CYTOCHROME C OXIDASE POLYPEPTIDE 7A1 CYTOCHROME C OXIDASE SUBUNIT 3)	5voc	ENVELOPE GLYCOPROTEIN H ENVELOPE GLYCOPROTEIN L (Human betaherpesvirus 5; Human betaherpesvirus 5)	4 / 5	PHE A 90 PHE A 80 LEU B 183 PHE B 222	None	1.11A	3ag3C-5vocA: 2.5 3ag3J-5vocA: undetectable	3ag3C-5vocA: 15.48 3ag3J-5vocA: 6.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3E23_A_SAMA221_0 (UNCHARACTERIZED PROTEIN RPA2492)	5voc	ENVELOPE GLYCOPROTEIN H (Human betaherpesvirus 5)	5 / 12	LEU A 313 PRO A 157 SER A 310 LEU A 148 LEU A 373	None	1.16A	3e23A-5vocA: undetectable	3e23A-5vocA: 14.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3GLQ_B_RABB602_2 (ADENOSYLHOMOCYSTEINA SE)	5voc	ENVELOPE GLYCOPROTEIN H (Human betaherpesvirus 5)	4 / 5	GLN A 151 THR A 153 THR A 414 HIS A 165	None	1.47A	3glqB-5vocA: undetectable	3glqB-5vocA: 21.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3KU9_B_SPMB700_1 (POLYAMINE OXIDASE)	5voc	ENVELOPE GLYCOPROTEIN H ENVELOPE GLYCOPROTEIN L (Human betaherpesvirus 5)	4 / 7	GLU B 182 TYR A 45 PHE A 81 TYR A 87	None	1.31A	3ku9B-5vocB: undetectable	3ku9B-5vocB: 20.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3LOQ_A_ACTA277_0 (UNIVERSAL STRESS PROTEIN)	5voc	ENVELOPE GLYCOPROTEIN UL130 ENVELOPE GLYCOPROTEIN UL131A (Human betaherpesvirus 5; Human betaherpesvirus 5)	3 / 3	ASP D 185 SER D 187 ARG E 104	None	1.02A	3loqA-5vocD: undetectable	3loqA-5vocD: 19.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3MZE_A_CFXA364_2 (D-ALANYL-D-ALANINE CARBOXYPEPTIDASE DACA)	5voc	ENVELOPE GLYCOPROTEIN H (Human betaherpesvirus 5)	3 / 3	SER A 689 SER A 688 HIS A 693	None	0.72A	3mzeA-5vocA: undetectable	3mzeA-5vocA: 19.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3N58_A_ADNA500_2 (ADENOSYLHOMOCYSTEINA SE)	5voc	ENVELOPE GLYCOPROTEIN H (Human betaherpesvirus 5)	4 / 5	GLN A 151 THR A 153 THR A 414 HIS A 165	None	1.47A	3n58A-5vocA: undetectable	3n58A-5vocA: 19.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3OU6_D_SAMD300_0 (SAM-DEPENDENT METHYLTRANSFERASE)	5voc	ENVELOPE GLYCOPROTEIN H (Human betaherpesvirus 5)	5 / 12	ALA A 351 GLY A 185 SER A 184 ASP A 146 LEU A 309	None	1.22A	3ou6D-5vocA: undetectable	3ou6D-5vocA: 14.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3OU7_A_SAMA300_0 (SAM-DEPENDENT METHYLTRANSFERASE)	5voc	ENVELOPE GLYCOPROTEIN H (Human betaherpesvirus 5)	5 / 12	ALA A 351 GLY A 185 SER A 184 ASP A 146 LEU A 309	None	1.24A	3ou7A-5vocA: undetectable	3ou7A-5vocA: 14.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3OU7_D_SAMD300_0 (SAM-DEPENDENT METHYLTRANSFERASE)	5voc	ENVELOPE GLYCOPROTEIN H (Human betaherpesvirus 5)	5 / 12	ALA A 351 GLY A 185 SER A 184 ASP A 146 LEU A 309	None	1.22A	3ou7D-5vocA: undetectable	3ou7D-5vocA: 14.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3PO7_A_ZONA601_1 (AMINE OXIDASE [FLAVIN-CONTAINING] B)	5voc	ENVELOPE GLYCOPROTEIN H (Human betaherpesvirus 5)	4 / 8	LEU A 348 GLN A 377 TYR A 344 TYR A 396	None	1.19A	3po7A-5vocA: undetectable	3po7A-5vocA: 21.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3Q70_A_RITA2001_2 (CANDIDAPEPSIN-2)	5voc	ENVELOPE GLYCOPROTEIN UL130 (Human betaherpesvirus 5)	4 / 6	SER D 103 ILE D 111 TYR D 89 THR D 54	None	1.00A	3q70A-5vocD: undetectable	3q70A-5vocD: 18.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3QF1_A_PZEA6951_1 (LACTOPEROXIDASE)	5voc	ENVELOPE GLYCOPROTEIN L (Human betaherpesvirus 5)	3 / 3	HIS B 177 ARG B 196 GLU B 198	None	1.04A	3qf1A-5vocB: undetectable	3qf1A-5vocB: 19.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3ROD_D_NCAD302_0 (NICOTINAMIDE N-METHYLTRANSFERASE)	5voc	ENVELOPE GLYCOPROTEIN H (Human betaherpesvirus 5)	4 / 7	LEU A 298 ASP A 299 ALA A 300 TYR A 320	None	1.19A	3rodD-5vocA: undetectable	3rodD-5vocA: 19.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3TJ7_C_ACTC610_0 (GBAA_1210 PROTEIN)	5voc	ENVELOPE GLYCOPROTEIN H (Human betaherpesvirus 5)	3 / 3	ASN A 315 ALA A 300 ARG A 319	None	0.88A	3tj7C-5vocA: undetectable 3tj7D-5vocA: undetectable	3tj7C-5vocA: 14.67 3tj7D-5vocA: 14.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4A97_E_ZPCE1318_2 (CYS-LOOP LIGAND-GATED ION CHANNEL)	5voc	ENVELOPE GLYCOPROTEIN H (Human betaherpesvirus 5)	4 / 6	GLU A 339 PHE A 342 VAL A 128 PHE A 297	None	1.17A	4a97E-5vocA: 3.6	4a97E-5vocA: 17.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4AX8_A_SAMA1474_1 (WBDD)	5voc	ENVELOPE GLYCOPROTEIN H (Human betaherpesvirus 5)	4 / 6	ARG A 421 ASP A 517 GLU A 499 LEU A 469	None	1.07A	4ax8A-5vocA: undetectable	4ax8A-5vocA: 21.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4DF3_A_SAMA301_1 (FIBRILLARIN-LIKE RRNA/TRNA 2'-O-METHYLTRANSFERA SE)	5voc	ENVELOPE GLYCOPROTEIN H (Human betaherpesvirus 5)	3 / 3	TYR A 306 THR A 272 GLU A 355	None	0.68A	4df3A-5vocA: undetectable	4df3A-5vocA: 14.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4DF3_B_SAMB301_1 (FIBRILLARIN-LIKE RRNA/TRNA 2'-O-METHYLTRANSFERA SE)	5voc	ENVELOPE GLYCOPROTEIN H (Human betaherpesvirus 5)	3 / 3	TYR A 306 THR A 272 GLU A 355	None	0.70A	4df3B-5vocA: undetectable	4df3B-5vocA: 14.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4F4D_B_CHDB504_0 (FERROCHELATASE, MITOCHONDRIAL)	5voc	ENVELOPE GLYCOPROTEIN L (Human betaherpesvirus 5)	4 / 4	LEU B 253 PRO B 254 LEU B 257 ILE B 219	None	0.82A	4f4dB-5vocB: undetectable	4f4dB-5vocB: 23.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4L1X_A_STRA402_1 (ALDO-KETO REDUCTASE FAMILY 1 MEMBER C2)	5voc	ENVELOPE GLYCOPROTEIN H (Human betaherpesvirus 5)	4 / 8	LEU A 469 TYR A 468 VAL A 420 HIS A 318	None	0.85A	4l1xA-5vocA: undetectable	4l1xA-5vocA: 18.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4OKB_A_198A1002_2 (ANDROGEN RECEPTOR)	5voc	ENVELOPE GLYCOPROTEIN H ENVELOPE GLYCOPROTEIN L (Human betaherpesvirus 5)	4 / 6	LEU A 106 ASN A 107 LEU B 72 VAL B 75	None	1.02A	4okbA-5vocA: undetectable	4okbA-5vocA: 15.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4RS0_A_IBPA706_1 (PROSTAGLANDIN G/H SYNTHASE 2)	5voc	ENVELOPE GLYCOPROTEIN H (Human betaherpesvirus 5)	5 / 9	VAL A 423 LEU A 426 SER A 427 LEU A 473 LEU A 440	None	0.96A	4rs0A-5vocA: undetectable	4rs0A-5vocA: 22.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4RVG_A_SAMA503_0 (D-MYCAROSE 3-C-METHYLTRANSFERAS E)	5voc	ENVELOPE GLYCOPROTEIN H ENVELOPE GLYCOPROTEIN L (Human betaherpesvirus 5; Human betaherpesvirus 5)	5 / 12	THR A 69 ASN A 79 ARG B 207 VAL B 191 ILE B 173	None	0.98A	4rvgA-5vocA: undetectable	4rvgA-5vocA: 20.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5B1B_C_CHDC306_0 (CYTOCHROME C OXIDASE SUBUNIT 3 CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL)	5voc	ENVELOPE GLYCOPROTEIN H ENVELOPE GLYCOPROTEIN L (Human betaherpesvirus 5; Human betaherpesvirus 5)	4 / 6	PHE A 90 PHE A 80 LEU B 183 PHE B 222	None	1.13A	5b1bC-5vocA: 2.5 5b1bJ-5vocA: undetectable	5b1bC-5vocA: 15.48 5b1bJ-5vocA: 6.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5BW4_B_SAMB301_1 (16S RRNA (ADENINE(1408)-N(1)) -METHYLTRANSFERASE)	5voc	ENVELOPE GLYCOPROTEIN H ENVELOPE GLYCOPROTEIN L (Human betaherpesvirus 5; Human betaherpesvirus 5)	3 / 3	ASP B 129 GLU B 94 SER A 68	None	0.71A	5bw4B-5vocB: undetectable	5bw4B-5vocB: 25.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5IY5_P_CHDP307_0 (CYTOCHROME C OXIDASE SUBUNIT 3 CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL)	5voc	ENVELOPE GLYCOPROTEIN H ENVELOPE GLYCOPROTEIN L (Human betaherpesvirus 5; Human betaherpesvirus 5)	4 / 5	LEU B 221 PHE B 222 LEU A 106 PHE B 174	None	1.14A	5iy5P-5vocB: undetectable 5iy5W-5vocB: undetectable	5iy5P-5vocB: 18.28 5iy5W-5vocB: 13.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5JVZ_B_FLPB601_1 (PROSTAGLANDIN G/H SYNTHASE 2)	5voc	ENVELOPE GLYCOPROTEIN H (Human betaherpesvirus 5)	5 / 12	VAL A 423 LEU A 426 SER A 427 LEU A 473 LEU A 440	None	1.13A	5jvzB-5vocA: undetectable	5jvzB-5vocA: 20.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5KPC_A_SAMA401_1 (PAVINE N-METHYLTRANSFERASE)	5voc	ENVELOPE GLYCOPROTEIN H ENVELOPE GLYCOPROTEIN L (Human betaherpesvirus 5; Human betaherpesvirus 5)	4 / 5	PHE A 138 SER A 139 ASN B 263 ASP A 265	None	1.17A	5kpcA-5vocA: undetectable	5kpcA-5vocA: 18.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5M66_D_ADND502_2 (ADENOSYLHOMOCYSTEINA SE)	5voc	ENVELOPE GLYCOPROTEIN H (Human betaherpesvirus 5)	3 / 3	THR A 557 THR A 337 LEU A 218	None	0.69A	5m66D-5vocA: undetectable	5m66D-5vocA: 19.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ND4_B_TA1B601_1 (TUBULIN BETA-2B CHAIN)	5voc	ENVELOPE GLYCOPROTEIN H (Human betaherpesvirus 5)	5 / 12	VAL A 490 GLU A 486 ALA A 447 ARG A 441 LEU A 440	None	1.11A	5nd4B-5vocA: undetectable	5nd4B-5vocA: 19.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5OEX_A_CUA604_0 (THIOCYANATE DEHYDROGENASE)	5voc	ENVELOPE GLYCOPROTEIN H (Human betaherpesvirus 5)	3 / 3	HIS A 512 HIS A 511 HIS A 509	None	0.86A	5oexA-5vocA: undetectable	5oexA-5vocA: 19.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5UMW_F_RBFF201_1 (GLYOXALASE/BLEOMYCIN RESISANCE PROTEIN/DIOXYGENASE)	5voc	ENVELOPE GLYCOPROTEIN H (Human betaherpesvirus 5)	4 / 7	LEU A 497 ARG A 534 VAL A 591 SER A 579	None	1.27A	5umwA-5vocA: undetectable 5umwF-5vocA: undetectable	5umwA-5vocA: 7.90 5umwF-5vocA: 7.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5VLM_B_CVIB301_1 (REGULATORY PROTEIN TETR)	5voc	ENVELOPE GLYCOPROTEIN L (Human betaherpesvirus 5)	4 / 8	GLY B 161 ARG B 166 TYR B 169 ASP B 163	None	1.01A	5vlmB-5vocB: undetectable	5vlmB-5vocB: 20.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5WAU_C_CHDC306_0 (CYTOCHROME C OXIDASE SUBUNIT 3 CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL)	5voc	ENVELOPE GLYCOPROTEIN H ENVELOPE GLYCOPROTEIN L (Human betaherpesvirus 5; Human betaherpesvirus 5)	4 / 5	PHE A 90 PHE A 80 LEU B 183 PHE B 222	None	1.11A	5wauC-5vocA: 2.7 5wauJ-5vocA: undetectable	5wauC-5vocA: 15.48 5wauJ-5vocA: 6.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5WAU_C_CHDC308_0 (CYTOCHROME C OXIDASE SUBUNIT 3 CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL)	5voc	ENVELOPE GLYCOPROTEIN H ENVELOPE GLYCOPROTEIN L (Human betaherpesvirus 5; Human betaherpesvirus 5)	4 / 5	PHE A 90 PHE A 80 LEU B 183 PHE B 222	None	1.06A	5wauc-5vocA: 2.7 5wauj-5vocA: undetectable	5wauc-5vocA: 15.48 5wauj-5vocA: 6.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5X1F_C_CHDC304_0 (CYTOCHROME C OXIDASE SUBUNIT 3 CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL)	5voc	ENVELOPE GLYCOPROTEIN H ENVELOPE GLYCOPROTEIN L (Human betaherpesvirus 5; Human betaherpesvirus 5)	4 / 5	LEU B 221 PHE B 222 LEU A 106 PHE B 174	None	1.07A	5x1fC-5vocB: undetectable 5x1fJ-5vocB: undetectable	5x1fC-5vocB: 19.32 5x1fJ-5vocB: 13.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5XDQ_C_CHDC308_0 (CYTOCHROME C OXIDASE SUBUNIT 3 CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL)	5voc	ENVELOPE GLYCOPROTEIN H ENVELOPE GLYCOPROTEIN L (Human betaherpesvirus 5; Human betaherpesvirus 5)	4 / 5	PHE A 90 PHE A 80 LEU B 183 PHE B 222	None	1.10A	5xdqC-5vocA: 2.7 5xdqJ-5vocA: undetectable	5xdqC-5vocA: 15.48 5xdqJ-5vocA: 6.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5XDQ_P_CHDP306_0 (CYTOCHROME C OXIDASE SUBUNIT 3 CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL)	5voc	ENVELOPE GLYCOPROTEIN H ENVELOPE GLYCOPROTEIN L (Human betaherpesvirus 5; Human betaherpesvirus 5)	4 / 5	PHE A 90 PHE A 80 LEU B 183 PHE B 222	None	1.09A	5xdqP-5vocA: 2.6 5xdqW-5vocA: undetectable	5xdqP-5vocA: 15.48 5xdqW-5vocA: 6.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5XDX_C_CHDC308_0 (CYTOCHROME C OXIDASE SUBUNIT 3 CYTOCHROME C OXIDASE SUBUNIT VIIA-HEART)	5voc	ENVELOPE GLYCOPROTEIN H ENVELOPE GLYCOPROTEIN L (Human betaherpesvirus 5; Human betaherpesvirus 5)	4 / 5	LEU B 221 PHE B 222 LEU A 106 PHE B 174	None	1.08A	5xdxC-5vocB: undetectable 5xdxJ-5vocB: undetectable	5xdxC-5vocB: 18.21 5xdxJ-5vocB: 13.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5XDX_P_CHDP306_0 (CYTOCHROME C OXIDASE SUBUNIT 3 CYTOCHROME C OXIDASE SUBUNIT VIIA-HEART)	5voc	ENVELOPE GLYCOPROTEIN H ENVELOPE GLYCOPROTEIN L (Human betaherpesvirus 5; Human betaherpesvirus 5)	4 / 5	LEU B 221 PHE B 222 LEU A 106 PHE B 174	None	1.17A	5xdxP-5vocB: undetectable 5xdxW-5vocB: undetectable	5xdxP-5vocB: 18.21 5xdxW-5vocB: 13.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5Y2O_A_8N6A501_1 (PEROXISOME PROLIFERATOR-ACTIVAT ED RECEPTOR GAMMA)	5voc	ENVELOPE GLYCOPROTEIN UL130 ENVELOPE GLYCOPROTEIN UL131A (Human betaherpesvirus 5)	5 / 12	PHE E 122 SER D 178 MET D 125 LEU E 56 LEU D 176	None	1.42A	5y2oA-5vocE: undetectable	5y2oA-5vocE: 17.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5Z84_J_CHDJ101_0 (CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL)	5voc	ENVELOPE GLYCOPROTEIN H (Human betaherpesvirus 5)	3 / 3	TYR A 135 ARG A 270 THR A 272	None	1.02A	5z84J-5vocA: undetectable	5z84J-5vocA: 6.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5Z84_P_CHDP305_0 (CYTOCHROME C OXIDASE SUBUNIT 3 CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL)	5voc	ENVELOPE GLYCOPROTEIN H ENVELOPE GLYCOPROTEIN L (Human betaherpesvirus 5; Human betaherpesvirus 5)	4 / 6	PHE A 90 PHE A 80 LEU B 183 PHE B 222	None	1.08A	5z84P-5vocA: 2.5 5z84W-5vocA: undetectable	5z84P-5vocA: 15.48 5z84W-5vocA: 6.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5Z85_P_CHDP307_0 (CYTOCHROME C OXIDASE SUBUNIT 3 CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL)	5voc	ENVELOPE GLYCOPROTEIN H ENVELOPE GLYCOPROTEIN L (Human betaherpesvirus 5; Human betaherpesvirus 5)	4 / 6	PHE A 90 PHE A 80 LEU B 183 PHE B 222	None	1.07A	5z85P-5vocA: 2.7 5z85W-5vocA: undetectable	5z85P-5vocA: 15.48 5z85W-5vocA: 6.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5Z86_C_CHDC306_0 (CYTOCHROME C OXIDASE SUBUNIT 3 CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL)	5voc	ENVELOPE GLYCOPROTEIN H ENVELOPE GLYCOPROTEIN L (Human betaherpesvirus 5; Human betaherpesvirus 5)	4 / 6	PHE A 90 PHE A 80 LEU B 183 PHE B 222	None	1.08A	5z86C-5vocA: 2.6 5z86J-5vocA: undetectable	5z86C-5vocA: 15.48 5z86J-5vocA: 6.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5Z86_P_CHDP307_0 (CYTOCHROME C OXIDASE SUBUNIT 3 CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL)	5voc	ENVELOPE GLYCOPROTEIN H ENVELOPE GLYCOPROTEIN L (Human betaherpesvirus 5; Human betaherpesvirus 5)	4 / 6	PHE A 90 PHE A 80 LEU B 183 PHE B 222	None	1.09A	5z86P-5vocA: 2.3 5z86W-5vocA: undetectable	5z86P-5vocA: 15.48 5z86W-5vocA: 6.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZCO_P_CHDP305_0 (CYTOCHROME C OXIDASE SUBUNIT 3 CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL)	5voc	ENVELOPE GLYCOPROTEIN H ENVELOPE GLYCOPROTEIN L (Human betaherpesvirus 5; Human betaherpesvirus 5)	4 / 6	PHE A 90 PHE A 80 LEU B 183 PHE B 222	None	1.09A	5zcoP-5vocA: 2.6 5zcoW-5vocA: undetectable	5zcoP-5vocA: 15.48 5zcoW-5vocA: 6.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZCP_C_CHDC306_0 (CYTOCHROME C OXIDASE SUBUNIT 3 CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL)	5voc	ENVELOPE GLYCOPROTEIN H ENVELOPE GLYCOPROTEIN L (Human betaherpesvirus 5; Human betaherpesvirus 5)	4 / 6	PHE A 90 PHE A 80 LEU B 183 PHE B 222	None	1.05A	5zcpC-5vocA: 2.6 5zcpJ-5vocA: undetectable	5zcpC-5vocA: 15.48 5zcpJ-5vocA: 6.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZCP_P_CHDP306_0 (CYTOCHROME C OXIDASE SUBUNIT 3 CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL)	5voc	ENVELOPE GLYCOPROTEIN H ENVELOPE GLYCOPROTEIN L (Human betaherpesvirus 5; Human betaherpesvirus 5)	4 / 6	PHE A 90 PHE A 80 LEU B 183 PHE B 222	None	1.06A	5zcpP-5vocA: undetectable 5zcpW-5vocA: undetectable	5zcpP-5vocA: 15.48 5zcpW-5vocA: 6.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6C06_D_FI8D1404_0 (DNA-DIRECTED RNA POLYMERASE SUBUNIT BETA DNA-DIRECTED RNA POLYMERASE SUBUNIT BETA')	5voc	ENVELOPE GLYCOPROTEIN H (Human betaherpesvirus 5)	4 / 8	ILE A 381 THR A 382 THR A 562 SER A 472	None	1.15A	6c06C-5vocA: 2.1	6c06C-5vocA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6F3N_A_ADNA505_2 (-)	5voc	ENVELOPE GLYCOPROTEIN H (Human betaherpesvirus 5)	4 / 4	GLN A 151 THR A 153 THR A 414 HIS A 165	None	1.50A	6f3nA-5vocA: undetectable	6f3nA-5vocA: 22.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6F3N_D_ADND506_2 (-)	5voc	ENVELOPE GLYCOPROTEIN H (Human betaherpesvirus 5)	4 / 4	GLN A 151 THR A 153 THR A 414 HIS A 165	None	1.50A	6f3nD-5vocA: undetectable	6f3nD-5vocA: 22.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6G9B_A_IXXA609_1 (ENVELOPE GLYCOPROTEIN,ENVELOP E GLYCOPROTEIN ENVELOPE GLYCOPROTEIN)	5voc	ENVELOPE GLYCOPROTEIN L (Human betaherpesvirus 5)	4 / 7	ILE B 86 LEU B 82 VAL B 151 LEU B 126	None	0.71A	6g9bA-5vocB: undetectable 6g9bB-5vocB: undetectable	6g9bA-5vocB: 17.49 6g9bB-5vocB: 16.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6MVX_A_K4DA1304_0 (ION TRANSPORT PROTEIN)	5voc	ENVELOPE GLYCOPROTEIN L (Human betaherpesvirus 5)	4 / 6	THR B 108 LEU B 111 THR B 130 LEU B 122	None	1.19A	6mvxA-5vocB: undetectable 6mvxB-5vocB: undetectable 6mvxC-5vocB: undetectable	6mvxA-5vocB: 19.68 6mvxB-5vocB: 19.68 6mvxC-5vocB: 19.68

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1FBM_B_RTLB951_0","PROTEIN (CARTILAGE OLIGOMERIC MATRIX PROTEIN)","5voc","ENVELOPE GLYCOPROTEIN H","Human betaherpesvirus 5",4,"THR A 453;LEU A 450;LEU A 469;GLN A 375","None","1.18A","1fbmA-5vocA:undetectable","1fbmA-5vocA:5.17"],["1L2I_B_CCSB417_0","ESTROGEN RECEPTOR","5voc","ENVELOPE GLYCOPROTEIN UL131A","Human betaherpesvirus 5",4,"PRO E  45;GLN E  47;LYS E  51;VAL E  53","None;None;NAG E 201 ( 4.9A);None","1.46A","1l2iB-5vocE:undetectable","1l2iB-5vocE:18.15"],["1SKX_A_RFPA1_2","ORPHAN NUCLEAR RECEPTOR PXR","5voc","ENVELOPE GLYCOPROTEIN H;ENVELOPE GLYCOPROTEIN L","Human betaherpesvirus 5",4,"PHE B 232;LEU B 246;MET A  92;LEU B  56","None","1.48A","1skxA-5vocB:undetectable","1skxA-5vocB:22.29"],["1UW6_D_NCTD1208_1","ACETYLCHOLINE-BINDING PROTEIN;ACETYLCHOLINE-BINDING PROTEIN","5voc","ENVELOPE GLYCOPROTEIN H;ENVELOPE GLYCOPROTEIN L","Human betaherpesvirus 5",4,"TYR A  61;CYH B 233;LEU A  96;MET A  92","None","1.46A","1uw6D-5vocA:undetectable;1uw6E-5vocA:undetectable","1uw6D-5vocA:14.07;1uw6E-5vocA:14.07"],["1UW6_G_NCTG1206_1","ACETYLCHOLINE-BINDING PROTEIN;ACETYLCHOLINE-BINDING PROTEIN","5voc","ENVELOPE GLYCOPROTEIN H;ENVELOPE GLYCOPROTEIN L","Human betaherpesvirus 5",4,"TYR A  61;CYH B 233;LEU A  96;MET A  92","None","1.49A","1uw6G-5vocA:undetectable;1uw6H-5vocA:undetectable","1uw6G-5vocA:14.07;1uw6H-5vocA:14.07"],["1UW6_P_NCTP1206_1","ACETYLCHOLINE-BINDING PROTEIN;ACETYLCHOLINE-BINDING PROTEIN","5voc","ENVELOPE GLYCOPROTEIN H;ENVELOPE GLYCOPROTEIN L","Human betaherpesvirus 5",4,"TYR A  61;CYH B 233;LEU A  96;MET A  92","None","1.47A","1uw6P-5vocA:undetectable;1uw6Q-5vocA:undetectable","1uw6P-5vocA:14.07;1uw6Q-5vocA:14.07"],["1UW6_T_NCTT1208_1","ACETYLCHOLINE-BINDING PROTEIN;ACETYLCHOLINE-BINDING PROTEIN","5voc","ENVELOPE GLYCOPROTEIN H;ENVELOPE GLYCOPROTEIN L","Human betaherpesvirus 5",4,"LEU A  96;MET A  92;TYR A  61;CYH B 233","None","1.42A","1uw6P-5vocA:undetectable;1uw6T-5vocA:undetectable","1uw6P-5vocA:14.07;1uw6T-5vocA:14.07"],["1Y0X_X_T44X500_2","THYROID HORMONE RECEPTOR BETA-1","5voc","ENVELOPE GLYCOPROTEIN H","Human betaherpesvirus 5",4,"ILE A 597;SER A 577;ARG A 528;LEU A 596","None","1.16A","1y0xX-5vocA:undetectable","1y0xX-5vocA:16.25"],["2OAX_F_SNLF6001_1","MINERALOCORTICOID RECEPTOR","5voc","ENVELOPE GLYCOPROTEIN H","Human betaherpesvirus 5",5,"LEU A 348;ALA A 345;LEU A 313;THR A 272;PHE A 250","None","1.46A","2oaxF-5vocA:undetectable","2oaxF-5vocA:15.76"],["2QD4_A_CHDA803_0","FERROCHELATASE","5voc","ENVELOPE GLYCOPROTEIN L","Human betaherpesvirus 5",4,"LEU B 253;PRO B 254;LEU B 257;ILE B 219","None","0.70A","2qd4A-5vocB:undetectable","2qd4A-5vocB:23.47"],["2R2V_D_ACTD36_0","GCN4 LEUCINE ZIPPER","5voc","ENVELOPE GLYCOPROTEIN H","Human betaherpesvirus 5",3,"SER A 316;TYR A 320;HIS A 318","None","0.81A","2r2vD-5vocA:undetectable","2r2vD-5vocA:3.66"],["2UVN_A_ECNA1409_1","CYTOCHROME P450 130","5voc","ENVELOPE GLYCOPROTEIN L","Human betaherpesvirus 5",5,"LEU B 123;ASP B 117;THR B 153;GLY B 161;LEU B  82","None","1.20A","2uvnA-5vocB:undetectable","2uvnA-5vocB:21.14"],["2V0M_D_KLND1498_1","CYTOCHROME P450 3A4","5voc","ENVELOPE GLYCOPROTEIN H","Human betaherpesvirus 5",5,"ILE A 227;ALA A 341;THR A 337;GLU A 221;LEU A 333","None","1.39A","2v0mD-5vocA:undetectable","2v0mD-5vocA:22.76"],["2W3B_B_FOLB401_1","DIHYDROFOLATE REDUCTASE","5voc","ENVELOPE GLYCOPROTEIN H","Human betaherpesvirus 5",3,"GLU A 466;GLN A 151;ARG A 365","None","0.98A","2w3bB-5vocA:undetectable","2w3bB-5vocA:13.10"],["2XNR_A_ACTA1001_0","NUCLEAR POLYADENYLATED RNA-BINDING PROTEIN 3","5voc","ENVELOPE GLYCOPROTEIN UL130","Human betaherpesvirus 5",3,"SER D  67;ARG D  66;GLN D  70","None","0.81A","2xnrA-5vocD:undetectable","2xnrA-5vocD:18.30"],["2Y69_C_CHDC1265_0","CYTOCHROME C OXIDASE POLYPEPTIDE 7A1;CYTOCHROME C OXIDASE SUBUNIT 3","5voc","ENVELOPE GLYCOPROTEIN H;ENVELOPE GLYCOPROTEIN L","Human betaherpesvirus 5;Human betaherpesvirus 5",4,"PHE A  90;PHE A  80;LEU B 183;PHE B 222","None","1.15A","2y69C-5vocA:2.5;2y69J-5vocA:undetectable","2y69C-5vocA:15.48;2y69J-5vocA:7.45"],["2Y69_P_CHDP1265_0","CYTOCHROME C OXIDASE POLYPEPTIDE 7A1;CYTOCHROME C OXIDASE SUBUNIT 3","5voc","ENVELOPE GLYCOPROTEIN H;ENVELOPE GLYCOPROTEIN L","Human betaherpesvirus 5;Human betaherpesvirus 5",4,"PHE A  90;PHE A  80;LEU B 183;PHE B 222","None","1.19A","2y69P-5vocA:2.6;2y69W-5vocA:undetectable","2y69P-5vocA:15.48;2y69W-5vocA:7.45"],["2ZZN_A_SAMA401_0","UNCHARACTERIZED PROTEIN MJ0883","5voc","ENVELOPE GLYCOPROTEIN H","Human betaherpesvirus 5",5,"ARG A 188;PHE A 234;ILE A 249;VAL A 236;PHE A 342","None","0.97A","2zznA-5vocA:undetectable","2zznA-5vocA:16.37"],["3ABL_P_CHDP1271_0","CYTOCHROME C OXIDASE POLYPEPTIDE 7A1;CYTOCHROME C OXIDASE SUBUNIT 3","5voc","ENVELOPE GLYCOPROTEIN H;ENVELOPE GLYCOPROTEIN L","Human betaherpesvirus 5;Human betaherpesvirus 5",4,"PHE A  90;PHE A  80;LEU B 183;PHE B 222","None","1.18A","3ablP-5vocA:2.6;3ablW-5vocA:undetectable","3ablP-5vocA:15.48;3ablW-5vocA:6.92"],["3ABM_C_CHDC271_0","CYTOCHROME C OXIDASE POLYPEPTIDE 7A1;CYTOCHROME C OXIDASE SUBUNIT 3","5voc","ENVELOPE GLYCOPROTEIN H;ENVELOPE GLYCOPROTEIN L","Human betaherpesvirus 5;Human betaherpesvirus 5",4,"PHE A  90;PHE A  80;LEU B 183;PHE B 222","None","1.14A","3abmC-5vocA:2.6;3abmJ-5vocA:undetectable","3abmC-5vocA:15.48;3abmJ-5vocA:6.92"],["3ABM_P_CHDP1271_0","CYTOCHROME C OXIDASE POLYPEPTIDE 7A1;CYTOCHROME C OXIDASE SUBUNIT 3","5voc","ENVELOPE GLYCOPROTEIN H;ENVELOPE GLYCOPROTEIN L","Human betaherpesvirus 5;Human betaherpesvirus 5",4,"PHE A  90;PHE A  80;LEU B 183;PHE B 222","None","1.16A","3abmP-5vocA:2.8;3abmW-5vocA:undetectable","3abmP-5vocA:15.48;3abmW-5vocA:6.92"],["3AG3_C_CHDC271_0","CYTOCHROME C OXIDASE POLYPEPTIDE 7A1;CYTOCHROME C OXIDASE SUBUNIT 3","5voc","ENVELOPE GLYCOPROTEIN H;ENVELOPE GLYCOPROTEIN L","Human betaherpesvirus 5;Human betaherpesvirus 5",4,"PHE A  90;PHE A  80;LEU B 183;PHE B 222","None","1.11A","3ag3C-5vocA:2.5;3ag3J-5vocA:undetectable","3ag3C-5vocA:15.48;3ag3J-5vocA:6.92"],["3E23_A_SAMA221_0","UNCHARACTERIZED PROTEIN RPA2492","5voc","ENVELOPE GLYCOPROTEIN H","Human betaherpesvirus 5",5,"LEU A 313;PRO A 157;SER A 310;LEU A 148;LEU A 373","None","1.16A","3e23A-5vocA:undetectable","3e23A-5vocA:14.90"],["3GLQ_B_RABB602_2","ADENOSYLHOMOCYSTEINASE","5voc","ENVELOPE GLYCOPROTEIN H","Human betaherpesvirus 5",4,"GLN A 151;THR A 153;THR A 414;HIS A 165","None","1.47A","3glqB-5vocA:undetectable","3glqB-5vocA:21.64"],["3KU9_B_SPMB700_1","POLYAMINE OXIDASE","5voc","ENVELOPE GLYCOPROTEIN H;ENVELOPE GLYCOPROTEIN L","Human betaherpesvirus 5",4,"GLU B 182;TYR A  45;PHE A  81;TYR A  87","None","1.31A","3ku9B-5vocB:undetectable","3ku9B-5vocB:20.74"],["3LOQ_A_ACTA277_0","UNIVERSAL STRESS PROTEIN","5voc","ENVELOPE GLYCOPROTEIN UL130;ENVELOPE GLYCOPROTEIN UL131A","Human betaherpesvirus 5;Human betaherpesvirus 5",3,"ASP D 185;SER D 187;ARG E 104","None","1.02A","3loqA-5vocD:undetectable","3loqA-5vocD:19.87"],["3MZE_A_CFXA364_2","D-ALANYL-D-ALANINE CARBOXYPEPTIDASE DACA","5voc","ENVELOPE GLYCOPROTEIN H","Human betaherpesvirus 5",3,"SER A 689;SER A 688;HIS A 693","None","0.72A","3mzeA-5vocA:undetectable","3mzeA-5vocA:19.19"],["3N58_A_ADNA500_2","ADENOSYLHOMOCYSTEINASE","5voc","ENVELOPE GLYCOPROTEIN H","Human betaherpesvirus 5",4,"GLN A 151;THR A 153;THR A 414;HIS A 165","None","1.47A","3n58A-5vocA:undetectable","3n58A-5vocA:19.43"],["3OU6_D_SAMD300_0","SAM-DEPENDENT METHYLTRANSFERASE","5voc","ENVELOPE GLYCOPROTEIN H","Human betaherpesvirus 5",5,"ALA A 351;GLY A 185;SER A 184;ASP A 146;LEU A 309","None","1.22A","3ou6D-5vocA:undetectable","3ou6D-5vocA:14.84"],["3OU7_A_SAMA300_0","SAM-DEPENDENT METHYLTRANSFERASE","5voc","ENVELOPE GLYCOPROTEIN H","Human betaherpesvirus 5",5,"ALA A 351;GLY A 185;SER A 184;ASP A 146;LEU A 309","None","1.24A","3ou7A-5vocA:undetectable","3ou7A-5vocA:14.84"],["3OU7_D_SAMD300_0","SAM-DEPENDENT METHYLTRANSFERASE","5voc","ENVELOPE GLYCOPROTEIN H","Human betaherpesvirus 5",5,"ALA A 351;GLY A 185;SER A 184;ASP A 146;LEU A 309","None","1.22A","3ou7D-5vocA:undetectable","3ou7D-5vocA:14.84"],["3PO7_A_ZONA601_1","AMINE OXIDASE [FLAVIN-CONTAINING] B","5voc","ENVELOPE GLYCOPROTEIN H","Human betaherpesvirus 5",4,"LEU A 348;GLN A 377;TYR A 344;TYR A 396","None","1.19A","3po7A-5vocA:undetectable","3po7A-5vocA:21.48"],["3Q70_A_RITA2001_2","CANDIDAPEPSIN-2","5voc","ENVELOPE GLYCOPROTEIN UL130","Human betaherpesvirus 5",4,"SER D 103;ILE D 111;TYR D  89;THR D  54","None","1.00A","3q70A-5vocD:undetectable","3q70A-5vocD:18.59"],["3QF1_A_PZEA6951_1","LACTOPEROXIDASE","5voc","ENVELOPE GLYCOPROTEIN L","Human betaherpesvirus 5",3,"HIS B 177;ARG B 196;GLU B 198","None","1.04A","3qf1A-5vocB:undetectable","3qf1A-5vocB:19.63"],["3ROD_D_NCAD302_0","NICOTINAMIDE N-METHYLTRANSFERASE","5voc","ENVELOPE GLYCOPROTEIN H","Human betaherpesvirus 5",4,"LEU A 298;ASP A 299;ALA A 300;TYR A 320","None","1.19A","3rodD-5vocA:undetectable","3rodD-5vocA:19.20"],["3TJ7_C_ACTC610_0","GBAA_1210 PROTEIN","5voc","ENVELOPE GLYCOPROTEIN H","Human betaherpesvirus 5",3,"ASN A 315;ALA A 300;ARG A 319","None","0.88A","3tj7C-5vocA:undetectable;3tj7D-5vocA:undetectable","3tj7C-5vocA:14.67;3tj7D-5vocA:14.67"],["4A97_E_ZPCE1318_2","CYS-LOOP LIGAND-GATED ION CHANNEL","5voc","ENVELOPE GLYCOPROTEIN H","Human betaherpesvirus 5",4,"GLU A 339;PHE A 342;VAL A 128;PHE A 297","None","1.17A","4a97E-5vocA:3.6","4a97E-5vocA:17.56"],["4AX8_A_SAMA1474_1","WBDD","5voc","ENVELOPE GLYCOPROTEIN H","Human betaherpesvirus 5",4,"ARG A 421;ASP A 517;GLU A 499;LEU A 469","None","1.07A","4ax8A-5vocA:undetectable","4ax8A-5vocA:21.39"],["4DF3_A_SAMA301_1","FIBRILLARIN-LIKE RRNA\/TRNA 2'-O-METHYLTRANSFERASE","5voc","ENVELOPE GLYCOPROTEIN H","Human betaherpesvirus 5",3,"TYR A 306;THR A 272;GLU A 355","None","0.68A","4df3A-5vocA:undetectable","4df3A-5vocA:14.44"],["4DF3_B_SAMB301_1","FIBRILLARIN-LIKE RRNA\/TRNA 2'-O-METHYLTRANSFERASE","5voc","ENVELOPE GLYCOPROTEIN H","Human betaherpesvirus 5",3,"TYR A 306;THR A 272;GLU A 355","None","0.70A","4df3B-5vocA:undetectable","4df3B-5vocA:14.44"],["4F4D_B_CHDB504_0","FERROCHELATASE, MITOCHONDRIAL","5voc","ENVELOPE GLYCOPROTEIN L","Human betaherpesvirus 5",4,"LEU B 253;PRO B 254;LEU B 257;ILE B 219","None","0.82A","4f4dB-5vocB:undetectable","4f4dB-5vocB:23.47"],["4L1X_A_STRA402_1","ALDO-KETO REDUCTASE FAMILY 1 MEMBER C2","5voc","ENVELOPE GLYCOPROTEIN H","Human betaherpesvirus 5",4,"LEU A 469;TYR A 468;VAL A 420;HIS A 318","None","0.85A","4l1xA-5vocA:undetectable","4l1xA-5vocA:18.54"],["4OKB_A_198A1002_2","ANDROGEN RECEPTOR","5voc","ENVELOPE GLYCOPROTEIN H;ENVELOPE GLYCOPROTEIN L","Human betaherpesvirus 5",4,"LEU A 106;ASN A 107;LEU B  72;VAL B  75","None","1.02A","4okbA-5vocA:undetectable","4okbA-5vocA:15.96"],["4RS0_A_IBPA706_1","PROSTAGLANDIN G\/H SYNTHASE 2","5voc","ENVELOPE GLYCOPROTEIN H","Human betaherpesvirus 5",5,"VAL A 423;LEU A 426;SER A 427;LEU A 473;LEU A 440","None","0.96A","4rs0A-5vocA:undetectable","4rs0A-5vocA:22.81"],["4RVG_A_SAMA503_0","D-MYCAROSE 3-C-METHYLTRANSFERASE","5voc","ENVELOPE GLYCOPROTEIN H;ENVELOPE GLYCOPROTEIN L","Human betaherpesvirus 5;Human betaherpesvirus 5",5,"THR A  69;ASN A  79;ARG B 207;VAL B 191;ILE B 173","None","0.98A","4rvgA-5vocA:undetectable","4rvgA-5vocA:20.57"],["5B1B_C_CHDC306_0","CYTOCHROME C OXIDASE SUBUNIT 3;CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL","5voc","ENVELOPE GLYCOPROTEIN H;ENVELOPE GLYCOPROTEIN L","Human betaherpesvirus 5;Human betaherpesvirus 5",4,"PHE A  90;PHE A  80;LEU B 183;PHE B 222","None","1.13A","5b1bC-5vocA:2.5;5b1bJ-5vocA:undetectable","5b1bC-5vocA:15.48;5b1bJ-5vocA:6.92"],["5BW4_B_SAMB301_1","16S RRNA (ADENINE(1408)-N(1))-METHYLTRANSFERASE","5voc","ENVELOPE GLYCOPROTEIN H;ENVELOPE GLYCOPROTEIN L","Human betaherpesvirus 5;Human betaherpesvirus 5",3,"ASP B 129;GLU B  94;SER A  68","None","0.71A","5bw4B-5vocB:undetectable","5bw4B-5vocB:25.33"],["5IY5_P_CHDP307_0","CYTOCHROME C OXIDASE SUBUNIT 3;CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL","5voc","ENVELOPE GLYCOPROTEIN H;ENVELOPE GLYCOPROTEIN L","Human betaherpesvirus 5;Human betaherpesvirus 5",4,"LEU B 221;PHE B 222;LEU A 106;PHE B 174","None","1.14A","5iy5P-5vocB:undetectable;5iy5W-5vocB:undetectable","5iy5P-5vocB:18.28;5iy5W-5vocB:13.06"],["5JVZ_B_FLPB601_1","PROSTAGLANDIN G\/H SYNTHASE 2","5voc","ENVELOPE GLYCOPROTEIN H","Human betaherpesvirus 5",5,"VAL A 423;LEU A 426;SER A 427;LEU A 473;LEU A 440","None","1.13A","5jvzB-5vocA:undetectable","5jvzB-5vocA:20.56"],["5KPC_A_SAMA401_1","PAVINE N-METHYLTRANSFERASE","5voc","ENVELOPE GLYCOPROTEIN H;ENVELOPE GLYCOPROTEIN L","Human betaherpesvirus 5;Human betaherpesvirus 5",4,"PHE A 138;SER A 139;ASN B 263;ASP A 265","None","1.17A","5kpcA-5vocA:undetectable","5kpcA-5vocA:18.87"],["5M66_D_ADND502_2","ADENOSYLHOMOCYSTEINASE","5voc","ENVELOPE GLYCOPROTEIN H","Human betaherpesvirus 5",3,"THR A 557;THR A 337;LEU A 218","None","0.69A","5m66D-5vocA:undetectable","5m66D-5vocA:19.59"],["5ND4_B_TA1B601_1","TUBULIN BETA-2B CHAIN","5voc","ENVELOPE GLYCOPROTEIN H","Human betaherpesvirus 5",5,"VAL A 490;GLU A 486;ALA A 447;ARG A 441;LEU A 440","None","1.11A","5nd4B-5vocA:undetectable","5nd4B-5vocA:19.64"],["5OEX_A_CUA604_0","THIOCYANATE DEHYDROGENASE","5voc","ENVELOPE GLYCOPROTEIN H","Human betaherpesvirus 5",3,"HIS A 512;HIS A 511;HIS A 509","None","0.86A","5oexA-5vocA:undetectable","5oexA-5vocA:19.68"],["5UMW_F_RBFF201_1","GLYOXALASE\/BLEOMYCIN RESISANCE PROTEIN\/DIOXYGENASE;GLYOXALASE\/BLEOMYCIN RESISANCE PROTEIN\/DIOXYGENASE","5voc","ENVELOPE GLYCOPROTEIN H","Human betaherpesvirus 5",4,"LEU A 497;ARG A 534;VAL A 591;SER A 579","None","1.27A","5umwA-5vocA:undetectable;5umwF-5vocA:undetectable","5umwA-5vocA:7.90;5umwF-5vocA:7.90"],["5VLM_B_CVIB301_1","REGULATORY PROTEIN TETR","5voc","ENVELOPE GLYCOPROTEIN L","Human betaherpesvirus 5",4,"GLY B 161;ARG B 166;TYR B 169;ASP B 163","None","1.01A","5vlmB-5vocB:undetectable","5vlmB-5vocB:20.57"],["5WAU_C_CHDC306_0","CYTOCHROME C OXIDASE SUBUNIT 3;CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL","5voc","ENVELOPE GLYCOPROTEIN H;ENVELOPE GLYCOPROTEIN L","Human betaherpesvirus 5;Human betaherpesvirus 5",4,"PHE A  90;PHE A  80;LEU B 183;PHE B 222","None","1.11A","5wauC-5vocA:2.7;5wauJ-5vocA:undetectable","5wauC-5vocA:15.48;5wauJ-5vocA:6.92"],["5WAU_C_CHDC308_0","CYTOCHROME C OXIDASE SUBUNIT 3;CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL","5voc","ENVELOPE GLYCOPROTEIN H;ENVELOPE GLYCOPROTEIN L","Human betaherpesvirus 5;Human betaherpesvirus 5",4,"PHE A  90;PHE A  80;LEU B 183;PHE B 222","None","1.06A","5wauc-5vocA:2.7;5wauj-5vocA:undetectable","5wauc-5vocA:15.48;5wauj-5vocA:6.92"],["5X1F_C_CHDC304_0","CYTOCHROME C OXIDASE SUBUNIT 3;CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL","5voc","ENVELOPE GLYCOPROTEIN H;ENVELOPE GLYCOPROTEIN L","Human betaherpesvirus 5;Human betaherpesvirus 5",4,"LEU B 221;PHE B 222;LEU A 106;PHE B 174","None","1.07A","5x1fC-5vocB:undetectable;5x1fJ-5vocB:undetectable","5x1fC-5vocB:19.32;5x1fJ-5vocB:13.95"],["5XDQ_C_CHDC308_0","CYTOCHROME C OXIDASE SUBUNIT 3;CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL","5voc","ENVELOPE GLYCOPROTEIN H;ENVELOPE GLYCOPROTEIN L","Human betaherpesvirus 5;Human betaherpesvirus 5",4,"PHE A  90;PHE A  80;LEU B 183;PHE B 222","None","1.10A","5xdqC-5vocA:2.7;5xdqJ-5vocA:undetectable","5xdqC-5vocA:15.48;5xdqJ-5vocA:6.92"],["5XDQ_P_CHDP306_0","CYTOCHROME C OXIDASE SUBUNIT 3;CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL","5voc","ENVELOPE GLYCOPROTEIN H;ENVELOPE GLYCOPROTEIN L","Human betaherpesvirus 5;Human betaherpesvirus 5",4,"PHE A  90;PHE A  80;LEU B 183;PHE B 222","None","1.09A","5xdqP-5vocA:2.6;5xdqW-5vocA:undetectable","5xdqP-5vocA:15.48;5xdqW-5vocA:6.92"],["5XDX_C_CHDC308_0","CYTOCHROME C OXIDASE SUBUNIT 3;CYTOCHROME C OXIDASE SUBUNIT VIIA-HEART","5voc","ENVELOPE GLYCOPROTEIN H;ENVELOPE GLYCOPROTEIN L","Human betaherpesvirus 5;Human betaherpesvirus 5",4,"LEU B 221;PHE B 222;LEU A 106;PHE B 174","None","1.08A","5xdxC-5vocB:undetectable;5xdxJ-5vocB:undetectable","5xdxC-5vocB:18.21;5xdxJ-5vocB:13.95"],["5XDX_P_CHDP306_0","CYTOCHROME C OXIDASE SUBUNIT 3;CYTOCHROME C OXIDASE SUBUNIT VIIA-HEART","5voc","ENVELOPE GLYCOPROTEIN H;ENVELOPE GLYCOPROTEIN L","Human betaherpesvirus 5;Human betaherpesvirus 5",4,"LEU B 221;PHE B 222;LEU A 106;PHE B 174","None","1.17A","5xdxP-5vocB:undetectable;5xdxW-5vocB:undetectable","5xdxP-5vocB:18.21;5xdxW-5vocB:13.95"],["5Y2O_A_8N6A501_1","PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA","5voc","ENVELOPE GLYCOPROTEIN UL130;ENVELOPE GLYCOPROTEIN UL131A","Human betaherpesvirus 5",5,"PHE E 122;SER D 178;MET D 125;LEU E  56;LEU D 176","None","1.42A","5y2oA-5vocE:undetectable","5y2oA-5vocE:17.97"],["5Z84_J_CHDJ101_0","CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL","5voc","ENVELOPE GLYCOPROTEIN H","Human betaherpesvirus 5",3,"TYR A 135;ARG A 270;THR A 272","None","1.02A","5z84J-5vocA:undetectable","5z84J-5vocA:6.92"],["5Z84_P_CHDP305_0","CYTOCHROME C OXIDASE SUBUNIT 3;CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL","5voc","ENVELOPE GLYCOPROTEIN H;ENVELOPE GLYCOPROTEIN L","Human betaherpesvirus 5;Human betaherpesvirus 5",4,"PHE A  90;PHE A  80;LEU B 183;PHE B 222","None","1.08A","5z84P-5vocA:2.5;5z84W-5vocA:undetectable","5z84P-5vocA:15.48;5z84W-5vocA:6.92"],["5Z85_P_CHDP307_0","CYTOCHROME C OXIDASE SUBUNIT 3;CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL","5voc","ENVELOPE GLYCOPROTEIN H;ENVELOPE GLYCOPROTEIN L","Human betaherpesvirus 5;Human betaherpesvirus 5",4,"PHE A  90;PHE A  80;LEU B 183;PHE B 222","None","1.07A","5z85P-5vocA:2.7;5z85W-5vocA:undetectable","5z85P-5vocA:15.48;5z85W-5vocA:6.92"],["5Z86_C_CHDC306_0","CYTOCHROME C OXIDASE SUBUNIT 3;CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL","5voc","ENVELOPE GLYCOPROTEIN H;ENVELOPE GLYCOPROTEIN L","Human betaherpesvirus 5;Human betaherpesvirus 5",4,"PHE A  90;PHE A  80;LEU B 183;PHE B 222","None","1.08A","5z86C-5vocA:2.6;5z86J-5vocA:undetectable","5z86C-5vocA:15.48;5z86J-5vocA:6.92"],["5Z86_P_CHDP307_0","CYTOCHROME C OXIDASE SUBUNIT 3;CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL","5voc","ENVELOPE GLYCOPROTEIN H;ENVELOPE GLYCOPROTEIN L","Human betaherpesvirus 5;Human betaherpesvirus 5",4,"PHE A  90;PHE A  80;LEU B 183;PHE B 222","None","1.09A","5z86P-5vocA:2.3;5z86W-5vocA:undetectable","5z86P-5vocA:15.48;5z86W-5vocA:6.92"],["5ZCO_P_CHDP305_0","CYTOCHROME C OXIDASE SUBUNIT 3;CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL","5voc","ENVELOPE GLYCOPROTEIN H;ENVELOPE GLYCOPROTEIN L","Human betaherpesvirus 5;Human betaherpesvirus 5",4,"PHE A  90;PHE A  80;LEU B 183;PHE B 222","None","1.09A","5zcoP-5vocA:2.6;5zcoW-5vocA:undetectable","5zcoP-5vocA:15.48;5zcoW-5vocA:6.92"],["5ZCP_C_CHDC306_0","CYTOCHROME C OXIDASE SUBUNIT 3;CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL","5voc","ENVELOPE GLYCOPROTEIN H;ENVELOPE GLYCOPROTEIN L","Human betaherpesvirus 5;Human betaherpesvirus 5",4,"PHE A  90;PHE A  80;LEU B 183;PHE B 222","None","1.05A","5zcpC-5vocA:2.6;5zcpJ-5vocA:undetectable","5zcpC-5vocA:15.48;5zcpJ-5vocA:6.92"],["5ZCP_P_CHDP306_0","CYTOCHROME C OXIDASE SUBUNIT 3;CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL","5voc","ENVELOPE GLYCOPROTEIN H;ENVELOPE GLYCOPROTEIN L","Human betaherpesvirus 5;Human betaherpesvirus 5",4,"PHE A  90;PHE A  80;LEU B 183;PHE B 222","None","1.06A","5zcpP-5vocA:undetectable;5zcpW-5vocA:undetectable","5zcpP-5vocA:15.48;5zcpW-5vocA:6.92"],["6C06_D_FI8D1404_0","DNA-DIRECTED RNA POLYMERASE SUBUNIT BETA;DNA-DIRECTED RNA POLYMERASE SUBUNIT BETA'","5voc","ENVELOPE GLYCOPROTEIN H","Human betaherpesvirus 5",4,"ILE A 381;THR A 382;THR A 562;SER A 472","None","1.15A","6c06C-5vocA:2.1","6c06C-5vocA:undetectable"],["6F3N_A_ADNA505_2","-","5voc","ENVELOPE GLYCOPROTEIN H","Human betaherpesvirus 5",4,"GLN A 151;THR A 153;THR A 414;HIS A 165","None","1.50A","6f3nA-5vocA:undetectable","6f3nA-5vocA:22.51"],["6F3N_D_ADND506_2","-","5voc","ENVELOPE GLYCOPROTEIN H","Human betaherpesvirus 5",4,"GLN A 151;THR A 153;THR A 414;HIS A 165","None","1.50A","6f3nD-5vocA:undetectable","6f3nD-5vocA:22.51"],["6G9B_A_IXXA609_1","ENVELOPE GLYCOPROTEIN,ENVELOPE GLYCOPROTEIN;ENVELOPE GLYCOPROTEIN","5voc","ENVELOPE GLYCOPROTEIN L","Human betaherpesvirus 5",4,"ILE B  86;LEU B  82;VAL B 151;LEU B 126","None","0.71A","6g9bA-5vocB:undetectable;6g9bB-5vocB:undetectable","6g9bA-5vocB:17.49;6g9bB-5vocB:16.10"],["6MVX_A_K4DA1304_0","ION TRANSPORT PROTEIN","5voc","ENVELOPE GLYCOPROTEIN L","Human betaherpesvirus 5",4,"THR B 108;LEU B 111;THR B 130;LEU B 122","None","1.19A","6mvxA-5vocB:undetectable;6mvxB-5vocB:undetectable;6mvxC-5vocB:undetectable","6mvxA-5vocB:19.68;6mvxB-5vocB:19.68;6mvxC-5vocB:19.68"]]